Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors (Q40356007)

From Wikidata
Jump to navigation Jump to search
scientific article published on 19 June 2010
edit
Language Label Description Also known as
English
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors
scientific article published on 19 June 2010

    Statements

    Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vgamma9Vdelta2 T lymphocyte agonist in patients with solid tumors (English)
    Jaafar Bennouna
    Hélène Sicard
    Hélène Senellart
    Frédéric Rolland
    Heriberto Bruzzoni-Giovanelli
    Céline Galéa
    Jérome Tiollier

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit